jdinternationalconsulting.com
Activities - JD Consulting
http://www.jdinternationalconsulting.com/activities
Skip to Main Content. JD consults with all sizes of public and private companies, universities and charities and also CROs. These include retained consultancies, ad hoc consultancies and scientific board memberships. JD is a non executive director of Xenogesis. He is also director of INMED. Drug Design and Drug Discovery. JD works with companies at all stages of drug design, drug discovery and early drug development covering:. All aspects from target selection via CD nomination to early clinical studies.
charnwood-molecular.com
Xenogesis | Charnwood Molecular Medicinal Chemistry and Pharmaceutical Chemicals Research UK
http://charnwood-molecular.com/partners/xenogesis
44 (0) 1509 232007. Process Research & Development. ULTImate YChemH – Compound Profiling. Nucleosides & Nucleotides. Dr David Lathbury – Astute Chemical Development Consultancy. Dr Richard Storer – Sandgate Point Consulting. Experts in DMPK/ADME, Xenogesis supports all key Discovery disciplines:. Physicochemical assays, in vitro DMPK/ADME assays, Cytochrome P450. Assays, metabolic stability, transporter studies, pharmacokinetics, bioanalysis,. Expert interpretation, customised laboratory services.
charnwood-molecular.com
Partners | Charnwood Molecular Medicinal Chemistry and Pharmaceutical Chemicals Research UK
http://charnwood-molecular.com/partners
44 (0) 1509 232007. Process Research & Development. ULTImate YChemH – Compound Profiling. Nucleosides & Nucleotides. Dr David Lathbury – Astute Chemical Development Consultancy. Dr Richard Storer – Sandgate Point Consulting. We are proud to work with other leading companies based at BioCity to offer an in-house seamless, integrated discovery and development service:. Http:/ www.xenogesis.com. Http:/ www.reachseparations.com. Http:/ www.sandexis.co.uk. Http:/ www.hybrigenics.com. 44 (0) 1509 232007.
e3bio.com
E3Bio - Business Strategy
http://e3bio.com/strategy.html
Is to see this potentially ground breaking novel medicine impacting patients lives without delay. The mission of E3Bio is to advance a stimulator of cell debris clearance to clinical proof of concept as quickly and efficiently as possible. The goal is to see this potentially ground breaking novel medicine impacting patients lives without delay. What is a virtual company? What is an asset-centric company? The term asset-centric is used to refer to biotech companies developing a single asset. This ensu...
SOCIAL ENGAGEMENT